NVIDIA Invests in Genesis Therapeutics to Advance AI-Powered Drug Development
Genesis Therapeutics, a London-based biotech company specializing in AI, receives funding from NVentures, NVIDIA's corporate venture capital arm, to develop its GEMS platform for drug discovery.